High UBE2O expression is correlated with poor prognosis (shorter overall/recurrence-free survival), larger tumor size, lymph node metastasis, higher histological grade, HER2 positivity, and a higher prevalence of the triple-negative breast cancer (TNBC) subtype [16]. This evidence concerns the gene UBE2O and neoplasm.